Delivery of BET Protein Degrader to Pancreatic Cancer & Their Microenvironment Via CEACAM6-Targeted Antibody–Drug Conjugate
Time: 12:00 pm
day: Day Two
Details:
- Analyzing Antibody protein degrader conjugate
- Understanding pancreatic cancer and its effects
- Reviewing a novel payload, BET protein degrader
